XML 22 R12.htm IDEA: XBRL DOCUMENT v3.25.3

Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2025

Accrued Liabilities and Other Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

​	​	​	​	​	​	​
​		As of
​	​	September 30,		​	December 31,
​	​	2025			2024
Accrued license fee	​	$	2,500	​	$	—
Accrued payroll-related costs	​	​	1,292	​	​	1,358
Accrued clinical costs	​	​	109	​	​	528
Accrued research and development costs	​	​	588	​	​	516
Accrued general and administrative costs	​	​	291	​	​	544
Other	​		8	​		5
Total accrued expenses and other current liabilities	​	$	4,788	​	$	2,951

​

​

X

- References

No definition available.

+ Details

Name:	us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for other liabilities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(24))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 405
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/405/tableOfContent

+ Details

Name:	us-gaap_OtherLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration